ALPS Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

ALPS Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,431	Closed	-$1.17M	–	1019
2024 Q1	$1.17M	Buy	33,431 +324	+1%	+$11.8K	0.01%	438
2023 Q4	$1.26M	Buy	+33,107	New	+$709K	0.01%	415

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

ALPS Advisors's INBX Position: Q2 2024 in Review

ALPS Advisors sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 33,431 shares — an estimated $1.17M sold.

ALPS Advisors first reported a position in INBX in Q4 2023 and held it in 2 quarters. The position peaked at $1.26M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

ALPS Advisors reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
ALPS Advisors sold 33,431 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.17M.
ALPS Advisors first reported a position in Inhibrx, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
ALPS Advisors's Inhibrx, Inc. Common Stock position peaked at $1.26M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on ALPS Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.